NewAmsterdam (NAMS) via Frazier Lifesciences (FLAC) deck
NewAmsterdam Pharma is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.
NewAmsterdam Pharma is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.
%20via%20Frazier%20Lifesciences%20(FLAC)%20deck){kind=link}